Answers are grounded in this paper and cite their sources.
Bidirectional Mendelian randomization study reveals both promoting and protective immune cells in ITP, suggesting complex immune interactions.
Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder affecting 3–6 per 100,000 adults annually, characterized by low platelet counts and increased bleeding risk.1 While dysregulated B and T cell responses are implicated, causal relationships between specific immune cell phenotypes and ITP remain unclear. Here, we applied bidirectional Mendelian randomization (MR), a genetic instrumental variable approach, to systematically evaluate causal links between 731 immune cell phenotypes and ITP. MR uses genetic variations as instrumental variables (IVs) to infer causality. Valid IVs must meet three key assumptions. (1) IVs are associated with the exposure factors; (2) IVs are independent of confounding factors; (3) IVs influence the outcome only through the exposure factors (Figure 1). We report this MR study with reference to the Strengthening the Reporting of Mendelian Randomization Studies (STROBE-MR) Guidelines.2 Genetic data were sourced from GWAS repositories: immunophenotypes derived from 3757 Sardinians; ITP data included 489,424 European-ancestry individuals (675 cases/488,749 controls). IVs were selected using genome-wide significance thresholds (forward MR: p < 5 × 10⁻⁸; reverse MR: p < 5 × 10⁻⁶) with linkage disequilibrium clumping (r² = 0.001). Primary analysis employed inverse variance weighted (IVW), supplemented by MR-Egger, weighted median, and weighted mode. Sensitivity analyses assessed heterogeneity (Cochran's Q and funnel plots), pleiotropy (MR-Egger intercept and scatter plots), and leave-one-out via R package TwoSampleMR (version 0.6.6). Our forward MR analysis identified 21 immune cells that were detected to have causal relationships with ITP. Specifically, 7 immune cells were identified as having promoting effects on ITP, while 14 were deemed protective. These 21 immune cells were categorized into B cell panels (11 cells), TBNK panels (3 cells), Treg panels (3 cells), Maturation stages of T cell panels (1 cell), cDC panels (2 cells), and myeloid cell panels (1 cell) (Supporting Information: Figure S1A). In the reverse MR analysis, the IVW results revealed causal associations between ITP and 731 immunophenotypes. To be specific, ITP was found to have causal relationships with 8 immune cells, including 1 cell in B cell panels, 3 cells in TBNK panels, 3 cells in monocyte panels and 1 cell in myeloid cell panels (Supporting Information: Figure S1B). Additionally, Cochran's Q test showed that there was no heterogeneity (p > 0.05), which was in line with the funnel plot (Supporting Information: Tables S1 and S2, Figures S2 and S3). What's more, no significant horizontal pleiotropy was found between these traits of exposures and outcomes (p > 0.05) (Supporting Information: Tables S1 and S2, Figures S4 and S5). The leave-one-out analysis indicated that MR analysis was not driven by a single SNP (Supporting Information: Figures S6 and S7). And SNP-related information is provided in Supporting Information: Tables S3 and S4. Mechanically, B cells play a crucial role in the development of ITP by secreting autoantibodies that target platelets for destruction through a process known as Fc receptor-mediated phagocytosis, leading to thrombocytopenia and an increased risk of bleeding. B cells continuously produce autoantibodies, particularly in the germinal centers of the spleen, where they mature into plasma cells. Rituximab, an anti-CD20 monoclonal antibody, is utilized therapeutically to deplete B cells through mechanisms such as complement-dependent cytotoxicity, antibody-dependent cellular cytotoxicity, and apoptosis, which helps reduce autoantibody production and alleviate ITP symptoms.3 Our study offers a novel perspective by emphasizing the protective role of CD20 expression on various B cell subsets, including IgD+ CD24−, IgD+ CD38br, IgD+ CD38dim, and transitional B cells, in preventing the onset of ITP. We suggest that higher levels of CD20 expression on B cells may increase their sensitivity to apoptotic signals, potentially speeding up the self-limiting nature of overactive B cell responses and consequently decreasing autoantibody production, which could help inhibit the progression of ITP. Early CD20-directed depletion could amplify this endogenous protective mechanism, establishing a critical intervention window before epitope spreading-induced disease amplification. Furthermore, our findings indicate that IgD on transitional B cells plays a role in the progression of ITP. This phenomenon is similar to other autoimmune diseases, such as systemic lupus erythematosus (SLE), where there is a notable increase in transitional B cells. In SLE, type I interferons found in patient plasma promote the survival of these cells by activating the nuclear factor kappa-B pathway and downregulating the pro-apoptotic protein Bax. The rise in transitional B cells leads to an increased production of the pro-inflammatory cytokine interleukin-6, exacerbating the activity of SLE. Similarly, targeting IgD to reduce transitional B-cell survival may attenuate inflammatory responses in ITP. In addition, our reverse MR analysis revealed increased CD27 expression on CD20− B cells in ITP patients. Although CD27 serves as a canonical surface marker for memory B cells, its dysregulated overexpression within this CD20− subset implies an anomalous memory-like or hyperactivated phenotype. Mechanistically, this dysregulation may involve microenvironmental remodeling and transcriptional reprogramming following B-cell depletion, potentially driving disease progression through amplified anti-apoptotic signaling and sustained secretion of pathogenic autoantibodies.4 The concurrent increase in hematopoietic stem cell activated cells in myeloid cells aligns with emerging evidence of bone marrow compensatory mechanisms in chronic thrombocytopenia, likely reflecting compensatory myelopoiesis triggered by systemic inflammation or hematopoietic stress secondary to accelerated platelet turnover. Clinically, the downregulation of human leukocyte antigen-DR isotype (HLA-DR) on monocyte subsets (CD14+CD16− and CD14+ monocytes) suggests impaired antigen-presenting capacity, potentially contributing to immune tolerance breakdown. This finding contrasts with previous observations of HLA-DR upregulation on macrophages in ITP patients, highlighting cell-type-specific dysregulation in antigen presentation pathways.5 This MR analysis boasts several strengths, including a bidirectional design that mitigates confounding and reverse causality concerns. The investigation leverages large-scale genetic data sets encompassing 489,424 participants, ensuring high statistical power to detect causal effects. Nevertheless, several limitations warrant consideration. First, achieving a comprehensive assessment of horizontal pleiotropy remains challenging, despite multiple sensitivity analyses. Second, the absence of individual-level data precluded the possibility of stratified population analyses. Lastly, the study's focus on European databases restricts the applicability of its findings to other ethnic populations. In summary, this study confirmed a causal relationship between 731 immune cell traits and ITP through MR, which highlights the significant influence that immunophenotypes have on the development and progression of ITP. Heyi Zhang, Luyao Song, and Mengxia Liu designed the study. Heyi Zhang, Ying Mao, and Jingfang Zhang collected and analyzed the data. Rui Zhao and Jing Luo contributed to data interpretation and visualization. Luyao Song, Zerui Liu, and Zhexi He participated in drafting the manuscript. All authors revised it for intellectual content and approved the final version for publication. Shengxiao Zhang had full access to all study data and was responsible for data integrity and the accuracy of data analysis. This study was supported by grants from the Natural Science Foundation of Shanxi Province (No. 202203021221269) and the National Natural Science Foundation of China (No. 82001740). We want to acknowledge the participants and investigators in the original research of this MR study. We thank the GWAS Catalog and IEU Open GWAS database for sharing these data. The authors declare no conflicts of interest. Not applicable. Only publicly available summary statistics were used. The raw data of this study were obtained from the GWAS public database https://gwas.mrcieu.ac.uk/), and all data were freely downloaded and used. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: